Articles by Daniel Marsh
Amphenol Shares Tumble 6% Amid Dividend, Debt, and AI Demand Story
Amphenol shares dropped 6% Friday, underperforming peers, even as the company reported record Q1 sales of $7.6 billion and announced a €1.1 billion senior notes offering.
Firefly Aerospace Gains 22% as Defense Contracts Boost Investor Sentiment
Firefly Aerospace stock jumped 22.6% to $39.68 Friday, driven by strong Q1 revenue and a Space Force contract win. Analysts see potential in defense and lunar programs.
Wall Street Hits New Highs on Tech Surge; Dow Flat Despite Jobs Data
The S&P 500 and Nasdaq hit record highs Friday, driven by AI and semiconductor stocks, while the Dow Jones barely budged after a solid jobs report.
AI Rally Drives S&P 500 and Nasdaq to New Highs Despite Oil Price Surge
The S&P 500 and Nasdaq closed at record highs Friday, driven by AI chip stocks and a better-than-expected April jobs report, even as oil prices climbed. Nvidia, Micron, and SanDisk posted strong gains.
Moderna Jumps 10% on Hantavirus Vaccine Push as Cruise Ship Outbreak Revives mRNA Hopes
Moderna shares rose 10% on Friday after the company revealed early-stage work on a hantavirus vaccine, spurred by a deadly Andes virus outbreak on the MV Hondius cruise ship.
Wynn Resorts Shares Slide on UAE Delay and $900M Macau Expansion
Wynn Resorts stock dropped 6.7% Friday despite beating Q1 profit estimates, as a delayed UAE opening and a $900M+ Macau expansion raised capital concerns.
Arbor Realty Trust Plunges After Dividend Cut and Weak Q1 Results
Arbor Realty Trust cut its dividend to $0.17 and reported Q1 net income of just $629,000, sending shares down 11% as investors focus on troubled loans.
Novavax Shares Surge on Pfizer Deal, Vaccine Strategy Shift
Novavax shares surged 13% Friday after Q1 revenue of $139.5 million beat estimates, fueled by a $30 million Pfizer licensing deal for Matrix-M adjuvant.
POET Technologies Stock Rebounds Amid Securities Lawsuit and Marvell Fallout
POET Technologies shares rebounded 14.5% to $10.97 on Friday, even as a securities lawsuit over tax disclosures and cancelled Celestial AI orders moves forward with a June 29 lead plaintiff deadline.
Traws Pharma Soars on Hantavirus Push After Cruise Fatalities
Traws Pharma shares surged over 21% after the biotech said it would advance hantavirus drug candidates following a fatal cruise ship outbreak. The company has no approved treatments and recently raised $10 million.
Eos Energy Shares Surge 22% Ahead of Earnings on AI Data Center Deal
Eos Energy shares surged 22% to $7.75 ahead of its May 13 earnings report, fueled by a joint development deal with TURBINE-X Energy for AI data center storage. Investors eye manufacturing rebound and legal hurdles.